The bounce back for healthcare stocks started back in May, but has faced some selling pressure in more recent trading sessions as market volatility grew. . However, over the last few days, prices of the iShares Nasdaq Biotech ETF (IBB) as well as the SPDR Healthcare ETF (XLV) have recovered from previous lows this week, and are now trending higher. Today’s premarket trading, may suggest that the bulls could be back in trading at least for the short term. As far as healthcare stocks are concerned, 2018 and most likely 2019 could be ready to see a jump in deals. According to a report from McKinsey & Company, the number of healthcare services deals among institutional investors nearly doubled from 2012 to 2017. McKinsey & Co. counted 225 deals in 2012 and 510 in 2017, reflecting a compound annual growth rate of 18%. In addition, the report found that healthcare spending is projected to increase 6 percent a year through 2025. Click Here For 3 Companies Looking To Profit From Healthcare Boom.